share_log

USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technologies Inc & Eurosets Srl | 17000+ Technavio Reports

USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technologies Inc & Eurosets Srl | 17000+ Technavio Reports

體外膜氧合機市場增長 239.83 億美元 | 阿朗科技股份有限公司和歐洲集團股份有限公司不斷發展的機會 | 17000+ 科技納維奧報告
PR Newswire ·  2021/11/30 06:16

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Technavio's latest offering, the Extracorporeal Membrane Oxygenation Machines Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The extracorporeal membrane oxygenation machines market value is expected to grow by USD 239.83 million, progressing at a CAGR of 10.27% as per the latest report by Technavio.

紐約, 二零二一年一月二十九日 /三通社/--科納維的最新產品,體外膜氧合機市場報告提供了各個地區的競爭情況和市場增長的詳細分析。體外膜氧合機的市場價值有望增長 二億九百八十三萬美元,在一個進展 複合年增長率(10.27%) 根據科納維奧的最新報告。

For more insights on the Extracorporeal Membrane Oxygenation Machines Market - Download a free sample now!

有關體外膜氧合機市場的更多見解- 立即下載免費樣品!

Attractive Opportunities in Extracorporeal Membrane Oxygenation Machines Market by Modality and Geography - Forecast and Analysis 2021-2025
通過模態和地理在體外膜氧合機市場中具有吸引力的機會-預測與分析 2021-2025

38% of the market's growth will originate from North America. US and Canada are the key markets for extracorporeal membrane oxygenation machines in the region. The rising number of new product launches will facilitate the extracorporeal membrane oxygenation machines market growth in North America 

38% 的市場增長將來自 北美洲。美國和 加拿大 是該地區體外膜氧合機的主要市場。新產品上市數量不斷增加將促進體外膜氧合機在北美市場的增長

Market Dynamics

市場動態

Factors such as the increasing incidence of respiratory and heart failure and the growing number of transplant procedures will drive the growth of the Extracorporeal Membrane Oxygenation Machines Market. However, high costs associated with cardiac and respiratory procedures might hamper the market growth.

因素如 呼吸和心臟衰竭的發生率增加,以及移植手術的數量不斷增加 將推動體外膜氧合機市場的增長。但是, 與心臟和呼吸手術相關的高成本 可能會妨礙市場增長。

Company Profiles

公司概況

The extracorporeal membrane oxygenation machines market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The extracorporeal membrane oxygenation machines market report includes information on the product launches, sustainability, and prospects of leading vendors including ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG, and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp.

體外膜氧合機市場是 支離破碎 供應商正在部署各種有機和無機的增長策略,以在市場上競爭。體外膜氧合機市場報告包括有關產品發布,可持續性和領先供應商的信息,包括阿朗科技股份有限公司,Eurosets Srl,Fresenius 醫療保健公司和 Co。KGAA,Getinge AB,利瓦諾娃 Plc,美敦力公司,微港科技股份有限公司,尼普羅公司,奧利根生物醫學股份有限公司和輝茂公司

Few Companies with Key Offerings

提供主要產品的少數公司

  • ALung Technologies Inc. - The company offers extracorporeal membrane oxygenation machines that provide ultra low flow, venovenous extracorporeal carbon dioxide removal using a single, 15.5 French dual lumen catheter inserted percutaneously in the femoral or jugular vein and removes 25 to 50 percent of basal metabolic CO2 production at circuit blood flows of 350 to 550 mL per minute, under the brand name of Hemolung RAS.
  • Eurosets Srl - The company offers extracorporeal membrane oxygenation machines that are designed to focus on optimal gas microemboli management and of its full coating with phosphorylcholine to work in a unique range of volumes, from less than 250 ml up to 2000 ml., under the brand name of Eurosets.
  • Fresenius Medical Care AG and Co - The company offers extracorporeal membrane oxygenation machines that enable gas exchange and circulation, respectively, when standard treatment fails thus providing clinicians time to treat patients, under the brand name of Xenios.
  • 鋁隆科技股份有限公司-該公司提供使用單一的 15.5 法國雙流明導管在股骨或頸靜脈中不斷插入股骨或頸靜脈中的靜脈靜脈靜脈內二氧化碳的體外膜氧合機,並在 RAS 品牌名稱下移除 25~50% 的基礎代謝二氧化碳生產 350 至 550 毫升的電路血液流量。
  • 歐洲集市 Srl-該公司提供旨在專注於最佳氣體微栓塞管理和其全塗層的磷酸膽鹼的體外膜氧合機,以在一個獨特的體積範圍內工作,從不到 250 毫升至 2000 毫升。,在 Eurosets 的品牌名稱下。
  • 費森尤斯醫療保健公司-該公司提供體外膜氧合機,分別在標準治療失敗時實現氣體交換和循環,從而以 Xenios 的品牌名稱為臨床醫生提供治療患者的時間。

Competitive Analysis

競爭力分析

The competitive scenario provided in the extracorporeal membrane oxygenation machines market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

體外膜氧合機市場報告中提供的競爭場景,根據各種性能指標進行分析,評估和定位公司。這項分析所考慮的因素包括過去數年公司的財務表現、增長策略、產品創新、新產品推出、投資、市場佔有率增長等。

Market Segmentation

市場細分

  • By Modality, the market is classified into  Veno-venous and Veno-arterial. The extracorporeal membrane oxygenation machines' market share growth by the Veno-venous segment has been significant. 
  • By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.
  • 通過模態,市場分為靜脈靜脈和靜脈動脈。體外膜氧合機的市場佔有率增長 靜脈段 一直很重要。
  • 按地理,市場被分類為 北美洲, 歐洲, 亞洲」和「列」。 北美洲 將擁有最大的市場份額。

Related Reports -
Neurodiagnostic and Monitoring Devices -The neurodiagnostic and monitoring devices market size in the US has the potential to grow by USD 443.81 million during 2020-2024.Download a free sample now!

相關報告-
神經診斷和監測設備-美國的神經診斷和監測設備市場規模具有增長的潛力 四億五千一百萬美元 二零二四年期間。立即下載免費樣品!

Chemiluminescence Immunoassay Analyzers Market -The chemiluminescence immunoassay (CLIA) analyzers market share is expected to increase by USD 3.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 10.32%. Download a free sample now!

化學性免疫分析儀市場-從 2021 年到 2026 年,化學發明免疫分析儀(CLIA)分析儀的市場份額預計將增加 324 億美元,市場的增長動力將以 10.32% 的複合年增長率加速。立即下載免費樣品!

Extracorporeal Membrane Oxygenation Machines Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 10.27%

Market growth 2021-2025

USD 239.83 million

Market structure

Fragmented

YoY growth (%)

8.87

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 38%

Key consumer countries

US, Germany, UK, Canada, China, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

體外膜氧合機市場範圍

報告範圍

詳情

頁碼

120

基準年

2020

預測週期

2021-2025

增長動力和複合年增長率

以 10.27% 的複合年增長率加速

市場增長

二億九百八十三萬美元

市場結構

碎片化

同比增長 (%)

8.87

區域分析

北美洲,歐洲,亞洲和羅馬

執行市場貢獻

在 38% 的北美地區

主要消費者國家

美國、德國、英國、加拿大、中國和法國

競爭格局

領先企業、競爭策略、消費者參與範圍

公司異形

阿朗科技股份有限公司,歐洲 Srl,費森尤斯醫療保健股份公司和股份有限公司KGAA,Getinge AB,利瓦諾娃 Plc,美敦力公司,微港科技股份有限公司,尼普羅公司,奧利根生物醫學股份有限公司和輝茂公司

市場動態

母市場分析,市場增長誘因和障礙,快速增長和緩慢增長的細分分析,COVID-19 影響和未來消費者動態,預測期的市場狀況分析

定制主題

如果我們的報告未包含您要查找的數據,您可以聯繫我們的分析師並定制細分。

About Us

關於我們

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio 是全球領先的技術研究和諮詢公司。他們的研究和分析專注於新興市場趨勢,並提供可行的見解,以幫助企業識別市場機會並制定有效的策略以優化其市場地位。Technavio 的報表庫擁有 500 多名專業分析師,包含超過 17,000 份報告和計數,涵蓋 800 種技術,橫跨 50 個國家。他們的客戶群由各種規模的企業組成,包括超過 100 家財富 500 強企業。這種不斷增長的客戶群依靠 Technavio 的全面覆蓋範圍、廣泛的研究和可行的市場洞察力,以識別現有和潛在市場中的機會,並評估其在不斷變化的市場場景中的競爭地位。

Contact

。聯繫

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]Website: www.technavio.com/

科技研究
杰西·梅达
媒體及市場推廣主任
我們:
英國:
電子郵件: [電子郵件保護]網站: 科技導航網

SOURCE Technavio

來源科技

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論